# Dexmedetomidine Use in Infants Undergoing Cooling Due to Neonatal Encephalopathy (DICE Trial)

> **NCT04772222** · PHASE2 · COMPLETED · sponsor: **University of Utah** · enrollment: 50 (actual)

## Conditions studied

- Hypoxic-Ischemic Encephalopathy
- Pain

## Interventions

- **DRUG:** Dexmedetomidine Hydrochloride
- **DRUG:** Morphine Sulfate

## Key facts

- **NCT ID:** NCT04772222
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-20
- **Primary completion:** 2025-01-17
- **Final completion:** 2025-12-31
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2026-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04772222

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04772222, "Dexmedetomidine Use in Infants Undergoing Cooling Due to Neonatal Encephalopathy (DICE Trial)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04772222. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*